HIV-prevention drug to be accessible for $40 a 12 months from 2027

Infectious illness specialists have hailed a transfer that can see a extremely efficient HIV prevention drug be bought at simply 40 {dollars} a 12 months in low and center earnings nations. Offers with Indian drug producers will see generic variations of the extremely efficient lenacapavir rolled out in 120 nations as of 2027. Specialists hope the broader accessibility of the drug will imply lowering the curb of the HIV epidemic. Story by Carys Garland.



Source link